Patient RBC protein analyses could help confirm changes in oxygen affinity, and studies on drugs that enhance Hb’s oxygen affinity may provide promising strategies to mitigate the haematological effects of COVID-19. The gene discussed is GSTM1; the disease is COVID-19.